[Fundamental and clinical studies on ceftazidime in the field of obstetrics and gynecology].
Fundamental and clinical studies were carried out on ceftazidime ( CAZ ), a new cephalosporin antibiotic, with the following results. Following each 1.0 g of drip infusion and bolus intravenous injection, transfer of CAZ to the internal genital organs was found to be good. Transfer of CAZ into exudate of the pelvic dead space was also good. CAZ was given to 6 cases. Clinical efficacy was good in 5 cases and poor in 1 case. No side effects were observed in any case. The above results demonstrated that CAZ is a safe and effective drug.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D002442:Ceftazidime; D002511:Cephalosporins / Q000378:metabolism*; D004341:Drug Evaluation; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D005836:Genitalia, Female / Q000378:metabolism*; D006801:Humans; D010388:Pelvis; D011247:Pregnancy
D002511:Cephalosporins; D002442:Ceftazidime